Hearscape
← Devices & Neurotechnology
Details checkedStrong evidenceCheckedregulatory

MED-EL SYNCHRONY Cochlear Implant System

Also known as: SYNCHRONY, SYNCHRONY 2, SONNET 3, MED-EL cochlear implant system

MED-EL

Primary source
Company
MED-EL
Program Type
Device
Modality
Cochlear/Auditory Implant
Stage
Marketed
Status
Marketed
Target Gene
—
Route / Mode
Implantable cochlear implant with external audio processor
Confidence
93%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-05-31
Geography
United States, Europe, Global
Population
pediatric, adult, bilateral, profound
Trial IDs
0
Mechanism

A cochlear implant system that electrically stimulates the auditory nerve to provide hearing sensation in severe-to-profound sensorineural hearing loss.

Indications
Hearing LossSensorineural Hearing Loss
Notes

One of the three globally important cochlear implant franchises; FDA PMA supplements confirm continuing lifecycle management of the U.S. platform.

Evidence & Sources
2 structured sources
company
Supports: canonicalName, company, programType, modality, indications, status, geography
Open
regulatory
Supports: mechanism, indications, stage, populationTags, notes
IDs: P000025, P000025S129
Open
Key Events
2024-10-03
FDA approval documentation published for a MED-EL cochlear implant system supplement
Related Programs
Apple AirPods Pro Hearing Health Features
Company: Apple · Hearing Aid/Software · Marketed
Nuance Audio Hearing Aid Software
Company: EssilorLuxottica · Hearing Aid/Software · Marketed
Cochlear Nucleus Nexa System
Company: Cochlear · Cochlear/Auditory Implant · Marketed
Envoy Medical Acclaim Cochlear Implant
Company: Envoy Medical · Cochlear/Auditory Implant · Phase 2/3
Phonak Audéo Sphere Infinio
Company: Phonak · Hearing Aid/Software · Marketed
Cochlear Nucleus Profile Plus CI600 Series Implants
Company: Cochlear · Cochlear/Auditory Implant · Marketed